1-2 of 2
Karin Schlangen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Maternal Embryonic Leucine Zipper Kinase (MELK) Drives a High-Risk Gene Network and Represents an Attractive Novel Drug Target in Multiple Myeloma

Arnold Bolomsky, PhD, Roy Heusschen, PhD, Karin Schlangen, PhD, Kathrin Schönfelder, MSc, Joséphine Muller, MSc, Wolfgang Schreiner, PhD, Niklas Zojer, MD, Jo Caers, Heinz Ludwig, MD
Journal: Blood
Blood (2016) 128 (22): 309.
https://doi.org/10.1182/blood.V128.22.309.309
Published: 2016
Journal Articles

Maternal Embryonic Leucine Zipper Kinase (MELK): a Novel Marker of Poor Prognosis and Attractive Drug Target in High-Risk Patients with Multiple Myeloma

Arnold Bolomsky, Karin Schlangen, Artur Köhler, Goran Mitulovic, Wolfgang Schreiner, Niklas Zojer, MD, Heinz Ludwig
Journal: Blood
Blood (2015) 126 (23): 1823.
https://doi.org/10.1182/blood.V126.23.1823.1823
Published: 2015